The Swiss drugmaker says the safety and efficacy of zosurabalpin will be investigated in a study involving 400 patients with ...

An experimental antibiotic, zosurabalpin, to fight a deadly superbug has entered the final human trials. Currently, no new ...

Acinetobacter baumannii are bacteria that cause infections in the blood, lungs, kidneys, brain, and other organs. These bacteria are nonmotile (don't move on their own), strictly aerobic (need ...

New ‘superbug’ antibiotic to treat sepsis and pneumonia enters last phase of testing - It is hoped that the drug zosurabalpin ...

Yet carbapenem-resistant Acinetobacter baumannii, or CRAB, is a nightmare for hospitals worldwide, as it kills roughly half of all patients who acquire it. Identified as a top-priority pathogen by ...

Australia’s second-largest private hospital operator, Healthscope, is in receivership with ten non-binding offers for ...

The bacteria, Acinetobacter baumannii, can cause serious infections in the lungs, urinary tract and blood, according to the US Centers for Disease Control and Prevention. It’s resistant to a ...

A. baumannii has strong drug pumps that push antibiotics, metals and other threats out of the cell. "By studying how this bug deals with infection stresses, we've found an important ...

The researchers focused on one of the most problematic species of bacteria - Acinetobacter baumannii, which can infect wounds and cause pneumonia. You may not have heard of it, but it is one of ...

Acinetobacter baumannii and the closely related genomic species 3 and 13TU are clinically the most important species. A. baumannii is a major cause of hospital-acquired infections in patients who ...

Hundreds of patients will be recruited for a major trial of what could be the first new antibiotic of its kind for 50 years.